Samya Z. Nasr
Expertise in
7
conditions

Dr. Samya Z. Nasr

Pediatric Pulmonology | Pediatrics
1540 E Hospital Dr, Floor 6 Reception C, 
Ann Arbor, MI 
Accepting New Patients
Expertise in
7
conditions
1540 E Hospital Dr, Floor 6 Reception C, 
Ann Arbor, MI 

Overview

Samya Nasr is a Pediatric Pulmonologist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan.

Dr. Nasr is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, Jaundice, and Gastrostomy.

She is actively involved in clinical research, co-authoring 72 peer reviewed articles and participating in 6 clinical trials. Dr. Nasr is currently accepting new patients.

Specialties

Pediatric Pulmonology
Pediatrics

Licenses

Pediatrics in MI

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Upper Peninsula Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
View 13 Less Insurance Carriers -

Locations

C. S. Mott Children's Hospital
1540 E Hospital Dr, Floor 6 Reception C, Ann Arbor, MI 48109

Additional Areas of Focus

Dr. Nasr has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Bronchopulmonary Dysplasia
Cystic Fibrosis

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

APPLAUD: A Double-Blind, Randomized, Placebo-Controlled, Phase II Study of the Efficacy and Safety of LAU-7b in the Treatment of Cystic Fibrosis in Adults
APPLAUD: A Double-Blind, Randomized, Placebo-Controlled, Phase II Study of the Efficacy and Safety of LAU-7b in the Treatment of Cystic Fibrosis in Adults
Enrollment Status: Completed
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drug: Fenretinide
Study Phase: Phase 2
A Phase III, Randomized, Double-blind, Placebo-controlled Study of AeroVanc for the Treatment of Persistent Methicillin-resistant Staphylococcus Aureus Lung Infection in Cystic Fibrosis Patients
A Phase III, Randomized, Double-blind, Placebo-controlled Study of AeroVanc for the Treatment of Persistent Methicillin-resistant Staphylococcus Aureus Lung Infection in Cystic Fibrosis Patients
Enrollment Status: Completed
Publish Date: December 16, 2022
Intervention Type: Drug
Study Phase: Phase 3
TEACH Trial: Testing the Effect of Adding CHronic Azithromycin to Inhaled Tobramycin. A Randomized, Placebo-controlled, Double-blinded Trial of Azithromycin 500mg Thrice Weekly in Combination With Inhaled Tobramycin
TEACH Trial: Testing the Effect of Adding CHronic Azithromycin to Inhaled Tobramycin. A Randomized, Placebo-controlled, Double-blinded Trial of Azithromycin 500mg Thrice Weekly in Combination With Inhaled Tobramycin
Enrollment Status: Completed
Publish Date: June 28, 2021
Intervention Type: Drug
Study Phase: Phase 4
DESIGN CF: Developing e-Health Systems to Improve Growth and Nutrition in CF Phase 2
DESIGN CF: Developing e-Health Systems to Improve Growth and Nutrition in CF Phase 2
Enrollment Status: Completed
Publish Date: February 02, 2021
Intervention Type: Behavioral
Study Phase: Not Applicable
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 Administered Orally Once-Daily for 48 Weeks in Adult Patients With Cystic Fibrosis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 Administered Orally Once-Daily for 48 Weeks in Adult Patients With Cystic Fibrosis
Enrollment Status: Completed
Publish Date: September 04, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Multi-Center Study of A New Method of Sweat Testing: The CF Quantum® Sweat Test
A Multi-Center Study of A New Method of Sweat Testing: The CF Quantum® Sweat Test
Enrollment Status: Terminated
Publish Date: August 31, 2018
Intervention Type: Device
View 5 Less Clinical Trials

72 Total Publications

Characterising cystic fibrosis in African populations: a scoping review protocol on phenotype, diagnosis, genetics and barriers to care.
Characterising cystic fibrosis in African populations: a scoping review protocol on phenotype, diagnosis, genetics and barriers to care.
Journal: BMJ open
Published: February 10, 2026
Similar Doctors
Expertise in
7
conditions
Dr. Antonia P. Popova
Pediatric Pulmonology | Pediatrics
Expertise in
7
conditions
Dr. Antonia P. Popova
Pediatric Pulmonology | Pediatrics
Referral may be required

C. S. Mott Children's Hospital

1540 E Hospital Dr, Floor 6 Reception C, 
Ann Arbor, MI 
 (0.1 miles away)
734-764-4123
Languages Spoken:
English, Bulgarian, Russian
See accepted insurances
Accepting New Patients

Antonia Popova is a Pediatric Pulmonologist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Popova is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Bronchopulmonary Dysplasia, Premature Infant, Congenital Unilateral Pulmonary Hypoplasia, and Cystic Fibrosis. Dr. Popova is currently accepting new patients.

Expertise in
14
conditions
Dr. Thomas G. Saba
Pediatric Pulmonology | Pediatrics
Expertise in
14
conditions
Dr. Thomas G. Saba
Pediatric Pulmonology | Pediatrics
Referral may be required

C. S. Mott Children's Hospital

1540 E Hospital Dr, Floor 6 Reception C, 
Ann Arbor, MI 
 (0.1 miles away)
734-764-4123
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients

Thomas Saba is a Pediatric Pulmonologist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Saba is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Situs Inversus, Ciliary Dyskinesia-Bronchiectasis, Primary Ciliary Dyskinesia (PCD), and Secondary Immunodeficiency (SID). Dr. Saba is currently accepting new patients.

Expertise in
19
conditions
Dr. Fauziya Hassan
Pediatric Pulmonology | Pediatrics | Sleep Medicine
Expertise in
19
conditions
Dr. Fauziya Hassan
Pediatric Pulmonology | Pediatrics | Sleep Medicine
Referral may be required

C. S. Mott Children's Hospital

1540 E Hospital Dr, Floor 6 Reception C, 
Ann Arbor, MI 
 (0.1 miles away)
734-615-4302
Languages Spoken:
English, Hindi, Urdu
See accepted insurances
Accepting New Patients

Fauziya Hassan is a Pediatric Pulmonologist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Hassan is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Central Sleep Apnea, Obstructive Sleep Apnea, Congenital Central Hypoventilation Syndrome, Duchenne Muscular Dystrophy, and Adenoidectomy. Dr. Hassan is currently accepting new patients.

Frequently Asked Questions about Dr. Samya Z. Nasr

How do I make an appointment with Dr. Samya Z. Nasr?

You can book an appointment with Dr. Samya Z. Nasr by calling their office at 734-764-4123. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Samya Z. Nasr a top-rated expert for Cystic Fibrosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Samya Z. Nasr is classified as an Elite expert for Cystic Fibrosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Samya Z. Nasr specialize in?

While Dr. Samya Z. Nasr is a Pediatric Pulmonology, they have specific expertise in Cystic Fibrosis, Secondary Immunodeficiency (SID), and Newborn Jaundice. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Pulmonology.

Does Dr. Samya Z. Nasr participate in research or clinical trials?

Yes. Dr. Samya Z. Nasr has published 72 articles and abstracts on conditions like Cystic Fibrosis. You can view a list of Dr. Samya Z. Nasr's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Samya Z. Nasr accept my insurance?

Dr. Samya Z. Nasr accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 734-764-4123 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nasr's expertise for a condition
ConditionClose
    View All 30 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile